Loading... Please wait...
Contact Us
Would you like more
information on this report
Please contact us today at +44(0)20.7665.9240
or +1 212.220.0880
or write to us.

Medical Affairs Reputations in Oncology (EU5): Oncologists Rate Key Products and Companies

Product Code:
596200313
Publication Date:
December 2014
Deliverables:
Report (PPT), Questionaire (PDF) & Data Tabulations (XLS)
Price:
$3,900

As the cancer drug market continues to face significant challenges in an environment of rising R&D costs, value-based pricing, demands for real world evidence and tougher regulation, the role of Medical Affairs teams in oncology working across the major markets of Europe – France, Germany, Italy, Spain and the UK; EU5 – becomes ever more critical.

Honing performance through smarter delivery, higher quality interaction, and effective communication with oncologists is vital for ensuring optimal performance levels of Medical Affairs teams.

In Medical Affairs Reputations in Oncology (EU5): Oncologists Rate Key Products and Companies, FirstWord provides robust insight on the performance and level of physician satisfaction with Medical Affairs teams representing 12 products in 4 key indications – Breast Cancer, Melanoma, Non-Small Cell Lung Cancer (NSCLC) and Renal Cell Carcinoma – across Europe’s most important markets.

Using proprietary analytics, EdgeMap and Need-Gap analysis, FirstWord offers important advanced analysis of the latest physician opinions on Medical Affairs that is both timely and critical for success in today’s oncology drugs markets.

Request Sample Pages

Key Benefits

  • Gain insight into how EU5 oncologists and haematologist-oncologists rate Medical Affairs teams in the areas of Breast Cancer, Melanoma, NSCLC and Renal Cell Carcinoma
  • Understand the key issues for which physicians require Medical Affairs team support
  • Learn which attributes physicians value most in relation to Medical Affairs team services
  • Identify which marketed and pipeline products were rated highest across numerous measures
  • Contrast and compare performance of Medical Affairs teams on multiple parameters – services, brand, indication and country
  • Determine which media and frequency of interaction is perceived most positively
  • Benefit from FirstWord's proprietary advanced analytics, EdgeMap and Need-Gap, to identify relative competitive positons and opportunities to develop advantage
  • Detailed multi-level comparative analysis of European Medical Affairs teams versus their US counterparts

em.pngWhat is EdgeMap Analysis?
This report includes advanced analysis of oncologists’ perceptions of Medical Affairs teams collected via an online survey. EdgeMap analysis, a proprietary analytics tool, provides an integrated, comparative analysis of the competitive set of products and attributes being evaluated in the study. It offers an overview of the market and provides a clear portrait of each product’s position within its competitive environment

 

needgap.pngWhat is Need-Gap Analysis?
This report includes slides that provide advanced analysis of oncologists’ perceptions of Medical Affairs teams collected via an online survey. Need-Gap analysis, a proprietary analytics tool, pinpoints areas of unmet need and provides valuable guidance on opportunities for corporate and brand positioning, and communication.

 

keyfacts.jpgKey Fact: Interviewing Methodology
Data was collected via a 15-minute Internet-based questionnaire.

 

sampledis.jpgKey Fact: Sample Distribution
210 medical oncologists and haematologist-oncologists across EU5 participated in this study.

 

kf.jpg Key Fact: Screening Criteria
- Have been in active practice between 5-35 years
- Devote at least 50% of time to direct patient care
- Have had direct interaction with a medical affairs professional in the past 6 months for at least one of the listed products

 

Report Features

Filled with charts and up-to-the-minute survey analysis, this report offers:

  • Precise and timely EdgeMap and Need-Gap analysis of oncologists' perceptions of Medical Affairs teams highlighting good and bad performance and identifying key areas for improvement
  • Overview of key rankings for eight marketed and four pipeline products
  • Examination of physicians' current touch points with Medical Affairs teams
  • Key findings regarding the attributes of Medical Affairs teams physicians value most and least
  • Comparative analysis of EU5 and US Medical Affairs teams at brand and attribute levels

 

Get Answers to Key Questions

  • How do oncologists perceive the role of Medical Affairs teams in the areas of Breast Cancer, Melanoma, NSCLC and Renal Cell Carcinoma?
  • How do physicians use the services of Medical Affairs teams?
  • What is the optimal frequency of interactions between Medical Affairs teams and physicians?
  • Within the competitive landscape of the EU5, what is each product’s position in terms of Medical Affairs services and support?
  • Which attributes of Medical Affairs teams are most likely to drive competitive advantage?
  • Which drugs provide the best service and claimed the highest ratings for Medical Affairs support?
  • What are the opportunities for corporate and brand positioning, and communication?

Request Sample Pages

Key Takeaways

Medical Affairs teams, Marketing Directors and Competitive Intelligence units can use this report to:

  • Precisely analyse physician needs and areas of concern
  • Improve team responsiveness and traction with oncologists
  • Deliver more effective messaging and tackle areas of weakness
  • Provide accurate, scientifically up-to-date product information in the areas of the most need
  • Understand how competitors are performing, where their performance leads or lags that of your team, and how big the gaps are
    • Tailor interaction frequency, media and approach

Related Report

us.pngMedical Affairs Reputations in Oncology (US): Oncologists Rate Key Products and Companies provides robust insight on the performance and physician satisfaction across 12 Medical Affairs teams across 4 key indications; Breast Cancer, Melanoma, Non-Small Cell Lung Cancer (NSCLC) and Renal Cell Carcinoma.

Using its proprietary analytics, EdgeMap and Need-Gap analysis, FirstWord offers an important new advanced analysis of survey results that is both timely and critical to the current oncology drugs market. Click here for more details.

About FirstView Reports

FirstView Reports deliver two types of research and analysis: FirstView Advisory and FirstView Trends. FirstView Advisory reports are based on the qualitative insights of 10-15 leading experts, including treating and key opinion leading physicians, payers and industry stakeholders. FirstView Trends reports deliver insights based on quantitative market research which leverages FirstWord’s 1-million strong online physician community. FirstView Advisory and FirstView Trends reports deliver authoritative, actionable insight that can help industry professionals understand future pharma market dynamics and support effective decision making.

About FirstWord Reports

FirstWord Reports deliver timely, need-to-know intelligence about your products, your competitors, and your markets. Covering market access, biosimilars, medical affairs, pharma sales and marketing and therapy areas, FirstWord Reports provide expert views and intelligence on the challenges facing pharma today.

Request Sample Pages




customer.service@firstwordpharma.com

All Contents Copyright © 2018 Doctor's Guide Publishing Limited All Rights Reserved